IJCS | Volume 32, Nº2, March/April 2019

123 1. Shrivastava AK, Singh HV, Raizada A, Singhd SK. C-reactive protein, inflammation and coronary heart disease. Egypt Heart J. 2015;67(2):89-97. 2. Yousuf O, Bibhu D, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, et al. High-sensitivity C-reactive protein and cardiovascular disease. A resolute belief or an elusive link? J Am Coll Cardiol. 2013;62(5):397-408. 3. Ridker PM. C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke. Circulation. 2003;108(12):e81-e85. 4. Correia LC, Esteves JP. C-Reactive protein and outcomes in acute coronary syndromes: a systematic review and meta-analysis. Arq Bras Cardiol. 2011;97(1):76-85. 5. Ridker PM. A test in context: high-sensitivity C-Reactive protein. J Am Coll Cardiol. 2016;67(6):712–23. 6. Swiatkiewicz I, Taub PR. The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failure. Kardiol Pol. 2018;76(5):821–9. 7. Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction. J Am Coll Cardiol. 2006;47(5):962–8. 8. Biasucci LM, Koenig W, Mair J, Mueller C, Plebani M, Lindahl B, et al. Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association of the European Society of Cardiology. How to use C-reactive protein in acute coronary care. Eur Heart J. 2013;34(48):3687–90. 9. Berton G, Cordiano R, Palmieri R, Pianca S, Pagliara V, Palatini P. C-reactive protein in acute myocardial infarction: association with heart failure. Am Heart J. 2003;145(6):1094–101. 10. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959-69. 11. Piva e Mattos LA, Berwanger O, Santos ES, Reis HJ, Romano ER, Petriz JL, et al. Clinical outcomes at 30 days in the Brazilian Registry of Acute Coronary Syndromes (ACCEPT). Arq Bras Cardiol. 2013;100(1):6-13. 12. Escosteguy CC, Portela MC, Medronho RA, de Vasconcellos MT. Acute myocardial infarction: clinical and epidemiological profile and factors associated with in-hospital death in the municipality of Rio de Janeiro. Arq Bras Cardiol. 2003;80(6):600-6,593-9. 13. Conrotto F, D'Ascenzo F, Humphries KH, Webb JG, Scacciatella P, Grasso C, et al. A meta-analysis of sex-related differences in outcomes after primary percutaneous intervention for ST-segment elevationmyocardial infarction. J Interv Cardiol. 2015;28(2):132-40. 14. McMechan SR, Adgey AA. Age related outome in acute myocardial infarction: elderly people benefit from thrombolysis and should be included in trials. BMJ. 1998;317(7169):1334-5. 15. Marcus FI, Friday K, McCans J, Moon T, Hahn E, Cobb L, et al. Age- related prognosis after acute myocardial infarction (The Multicenter Diltiazem Post-Infarction Trial). Am J Cardiol. 1990;65(9):559-66. 16. Barakat K, Wilkinson P, Deaner A, Fluck D, Ranjadayalan K, Timmis A. How should age affect management of acute myocardial infarction? A Prospective Cohort Study. Lancet. 1999;353(9157):955-9. 17. Ribeiro DR, Ramos AM, Vieira PL, Menti E, Bordin Jr OL, Souza PAL. Proteína C-Reativa prediz eventos cardiovasculares após infarto do miocárdio com elevação do ST? Arq Bras Cardiol. 2014;103(1):69-75. 18. Izumiya Y, Hanatani S, Kimura Y, Takashio S, Yamamoto E, Kusaka H, et al. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction. Can J Cardiol. 2014;30(3):338-44. 19. Makrygiannis SS, AmpartzidouOS, ZairisMN, PatsourakosNG, Pitsavos C, Tousoulis D, et al. Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acutemyocardial infarction. Am J Cardiol. 2013;111(1):26–30. 20. James S, Oldgren J, Lindback J, Johnston N, Siegbahn A, Wallentin. An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease. Am Heart J. 2005;149(4):619–26. 21. Anzai T. Post-infarction inflammation and left ventricular remodeling: a double-edged sword. Circ J. 2013;77(3):580–7. 22. Seropian IM, Sonnino C, Van Tassell BW, Biasucci LM, Abbate A. Inflammatory markers in ST-elevation acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2016;5(4):382–95. 23. Minamisawa M, Motoki H, Izawa A, Kashima Y, Hioki H, Abe N, et al. Comparison of inflammatory biomarkers in outpatients with prior myocardial infarction. Int Heart J. 2016;57(1):11-7. 24. SchoenhagenM. Current developments in atherosclerosis research. New York: Nova Biomedical Books; 2005. References Milano et al. C-reactive protein as a predictor of mortality Int J Cardiovasc Sci. 2019;32(2)118-124 Original Article Milano SM, Lenci GL. Critical revision of the manuscript for intellectual content: Lenci GL. Potential conflict of interest No potential conflict of interest relevant to this article was reported. Sources of funding There were no external funding sources for this study. Study association This article is part of the academic work submitted by Sibele Sauzem Milano to the Universidade Federal do Paraná in partial fulfillment of the requirements for the Bachelor’s degree Medicine. Acknowledgment The authors thank Ricardo Petterle for his valuable help in statistics. Ethics approval and consent to participate This article does not contain any studies with human participants or animals performed by any of the authors.